Last reviewed · How we verify
NCT06814093
Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: a Target Trial Emulation
trial testing Robotic surgery in Rectal Cancer in 2,702 participants. Participants enrolled and being followed up; not accepting new ones.
30 April 2025
Quick facts
| Lead sponsor | Xu jianmin |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 2,702 |
| Start date | 1 January 2021 |
| Primary completion | 30 April 2025 |
| Estimated completion | 30 April 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Robotic surgery
- Laparoscopic surgery
Conditions studied
- Rectal Cancer — all drugs for Rectal Cancer →
Sponsor
Xu jianmin — full company profile →
Who can join
Adults 18 to 80, any sex, with Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare the effectiveness of robotic surgery versus laparoscopic surgery in treating low rectal cancer. While robotic surgery has gained popularity, there is limited long-term evidence regarding its outcomes. By using real-world data from a specialized multicenter colorectal cancer database in Shanghai, China, this retrospective cohort study will emulate the target trial to evaluate whether robotic surgery offers advantages over laparoscopic surgery. Key factors such as disease-free survival, locoregional recurrence, circumferential margin positivity, and postoperative complications will be examined. The goal is to provide stronger, evidence-based support for the clinical use of robotic surgery in treating low rectal cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06814093
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Robotic surgery
Trials testing the same drug.
- NCT05611840 — RCT on Robotic vs. Endo-laparoscopic Approach for Difficult Choledocholithiasis · NA · unknown
- NCT05674227 — Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan · unknown
- NCT05089513 — Uterus Transplantation by Robotics - Gothenburg III · NA · terminated
- NCT04777565 — Study of a Minimally Invasive Cochlear Access for Cochlear Implantation Via a Robotic Procedure · NA · completed
- NCT05961423 — Robotic vs Laparoscopic D3-D4 Lymphadenectomy for Colorectal Cancer · NA · unknown
Other recruiting trials for Rectal Cancer
Currently open trials in the same condition.
- NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
- NCT07537998 — Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a · Phase 2, PHASE3 · recruiting
- NCT07501845 — Registry Maastro Applicator · recruiting
- NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres · NA · recruiting
- NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting
Other Xu jianmin trials
Trials by the same sponsor.
- NCT04118933 — A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer · Phase 2 · unknown
- NCT03895723 — Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases · NA · unknown
- NCT02642978 — Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases · NA · unknown
- NCT02944188 — Laparoscopic Versus Open Right Hemicolectomy Within ERAS in Right-sided Colon Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06814093 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xu jianmin
- Last refreshed: 9 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06814093.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing